Understanding pgt-a testing
PGT-A screens cells sampled from an embryo for differences in chromosome number. It can provide additional information for embryo selection within an IVF cycle. Whether to use it should be an individual decision made with your clinical team.
Who may discuss this option?
PGT-A is discussed individually in the context of IVF, medical history and embryo transfer planning. It is not automatically beneficial for every patient.
Before your consultation
- Previous IVF and embryo reports, including any genetic testing.
- Pregnancy and miscarriage history where relevant.
- Any known inherited condition or previous chromosome result, so the correct type of testing can be discussed.
What your care may involve
Discussion of indications and limitations
IVF and embryo culture
Embryo biopsy when appropriate
Laboratory chromosome analysis
Results counselling and transfer planning
Things to discuss with your doctor
- PGT-A is a screening test and cannot identify every genetic or health condition.
- It does not guarantee implantation or a healthy baby, and it is not appropriate for every patient.
- Results may be inconclusive or mosaic. Discuss the implications and prenatal testing options with a qualified clinician.
Alternatives and individual decisions
Options may include transfer without PGT-A or a different diagnostic pathway when a specific inherited condition is involved. A screening result does not replace discussion of prenatal testing.
Is PGT-A the same as testing for a specific inherited condition?
No. PGT-A screens chromosome number. Testing for a known single-gene condition involves a different process and needs specific genetic counselling.
